Voyager Therapeutics (VYGR) Tops Q1 EPS by 6c

Voyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of ($0.47), $0.06 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $8.17 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• JPMorgan Upgrades Yangzijiang Shipbuilding (YZJSGD:SP) (YSHLF) to Overweight
• Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
• JPMorgan Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral